Cosmecoin, develop by iConsult, is a blockchain-powered, comprehensive solution for issues within the Cosmetic Surgery and Medical Aesthetic industries.
Leveraging blockchain technology to create first of its kind marketplace for cosmetic surgery practitioners and patients.
They know that by using Cosmecoin they will connect with a Trusted Partner offering the best customer service and care.
Read MorePatients benefit from safe storage and easy access to their medical data including treatment history.
Read MoreThe practitioner will benefit from the ClinicOS software, new patients, reliable client feedback, secure storage of client medical data and the Cosmecoin reward scheme.
Read More
Connects consumers with Trusted
Exclusive engaging online
Connects your data
Informative and educational news feed
Tools for analysis and business growth
Transparent process creates accountability
Award winning software 2016
Practitioner qualifications and memberships
iConsult will be the first to develop a blockchain-based solution for the Cosmetic Surgery and Medical Aesthetics industries. This platform has the potential to be the market leader in this industry and change the way the consumer connects with the industry for ever
Following the presale, the crowd-sale will commence and the gathered funds will be used to create a team of front and back end developers for the ClinicOS Platform, the creation of the Minimum Viable Product (MVP) which includes the programming and launching of the trusted feedback platform, CRM Features, supporting tools, and the payment and aftercare mobile app.
In order to participate in the crowd-sale, each purchaser will be required to register on our whitelist. This whitelist will confirm your country of origin and require you to provide information that ensures you are, by law, allowed to participate in the sale of the COSX token.
| Stage 1 | Token Amount | Token Price (USD) | % Paid | Token Price (USD) |
|---|---|---|---|---|
| Pre sale | 65,000,000 | $0.037000 | 30% | $0.011100 |
| Stage 1 | 100,000,000 | $0.037000 | 50% | $0.018500 |
| Stage 2 | 10,000,000 | $0.037000 | 70% | $0.025900 |
| Stage 3 | 35,000,000 | $0.037000 | 90% | $0.033300 |
| Total | 300,000,000 | |||
The information to which this website gives access is exclusively intended for persons who are not located in or resident of certain other restricted jurisdictions, and who are otherwise permitted to receive such information. The information to which this website gives access does not constitute an offer or an invitation to purchase securities of IConsult Software Ltd (iConsult) in the United States, Canada, Japan, South Africa, the People’s Republic of China, the Republic of Korea or the Russian Federation or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or invitation. Potential users of this information are requested to inform themselves about and to observe any such restrictions.
iConsult’s securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act) or the securities laws of any state or other jurisdiction of the United States and iConsult has not and does not intend to register as an Investment Company under the U.S. Investment Company Act of 1940, as amended. Accordingly, iConsult’s securities may not be offered, sold, pledged, assigned, delivered or otherwise transferred, exercised or redeemed, at any time, within the United States or to, or for the account or benefit of, U.S. Persons. Any purported offer, sale or transfer of iConsult’s securities in violation of this provision shall be null and void ab initio and will not be honoured.
As used herein, “U.S. person” has the meaning ascribed to such term under Regulation S of the Securities Act.
To continue, please select the country you are located in and indicate that you have read and agree to the above.
By proceeding to view the materials to which this website gives access, you warrant that you are not (i) physically present in the United States and or located in or resident of Italy, France, Germany, Spain, Canada, Japan, the People’s Republic of China, the Republic of Korea or South Africa or any other jurisdiction in which the distribution of such materials is restricted, or in which the offer or invitation to purchase tokens proposed to be issued by iConsult is not authorised, or (ii) a person to whom such offer or invitation may be unlawful. You further agree that you will not transmit or otherwise send any information to which this website gives access to any person in any jurisdiction in which the distribution of such information is restricted, or in which the offer or invitation to purchase tokens proposed to be issued by iConsult is not authorised, or to whom such offer or invitation may be unlawful.
